Vanguard Group’s Neurocrine Biosciences NBIX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.23B | Sell |
9,807,066
-134,821
| -1% | -$16.9M | 0.02% | 604 |
|
2025
Q1 | $1.1B | Sell |
9,941,887
-177,754
| -2% | -$19.7M | 0.02% | 611 |
|
2024
Q4 | $1.38B | Buy |
10,119,641
+122,681
| +1% | +$16.7M | 0.02% | 564 |
|
2024
Q3 | $1.15B | Sell |
9,996,960
-59,486
| -0.6% | -$6.85M | 0.02% | 613 |
|
2024
Q2 | $1.38B | Buy |
10,056,446
+125,520
| +1% | +$17.3M | 0.03% | 540 |
|
2024
Q1 | $1.37B | Buy |
9,930,926
+220,598
| +2% | +$30.4M | 0.03% | 558 |
|
2023
Q4 | $1.28B | Buy |
9,710,328
+150,485
| +2% | +$19.8M | 0.03% | 557 |
|
2023
Q3 | $1.08B | Sell |
9,559,843
-10,875
| -0.1% | -$1.22M | 0.03% | 574 |
|
2023
Q2 | $903M | Sell |
9,570,718
-26,814
| -0.3% | -$2.53M | 0.02% | 649 |
|
2023
Q1 | $971M | Buy |
9,597,532
+257,237
| +3% | +$26M | 0.02% | 601 |
|
2022
Q4 | $1.12B | Buy |
9,340,295
+339,332
| +4% | +$40.5M | 0.03% | 541 |
|
2022
Q3 | $956M | Buy |
9,000,963
+96,489
| +1% | +$10.2M | 0.03% | 575 |
|
2022
Q2 | $868M | Buy |
8,904,474
+127,016
| +1% | +$12.4M | 0.02% | 609 |
|
2022
Q1 | $823M | Sell |
8,777,458
-10,533
| -0.1% | -$987K | 0.02% | 697 |
|
2021
Q4 | $748M | Sell |
8,787,991
-100,479
| -1% | -$8.56M | 0.02% | 775 |
|
2021
Q3 | $852M | Sell |
8,888,470
-96,151
| -1% | -$9.22M | 0.02% | 706 |
|
2021
Q2 | $874M | Buy |
8,984,621
+155,346
| +2% | +$15.1M | 0.02% | 702 |
|
2021
Q1 | $859M | Buy |
8,829,275
+492,010
| +6% | +$47.8M | 0.02% | 682 |
|
2020
Q4 | $799M | Buy |
8,337,265
+175,732
| +2% | +$16.8M | 0.02% | 668 |
|
2020
Q3 | $785M | Sell |
8,161,533
-317,806
| -4% | -$30.6M | 0.03% | 593 |
|
2020
Q2 | $1.03B | Sell |
8,479,339
-24,349
| -0.3% | -$2.97M | 0.04% | 489 |
|
2020
Q1 | $736M | Buy |
8,503,688
+186,791
| +2% | +$16.2M | 0.03% | 526 |
|
2019
Q4 | $894M | Buy |
8,316,897
+100,511
| +1% | +$10.8M | 0.03% | 578 |
|
2019
Q3 | $740M | Buy |
8,216,386
+99,017
| +1% | +$8.92M | 0.03% | 625 |
|
2019
Q2 | $685M | Sell |
8,117,369
-38,488
| -0.5% | -$3.25M | 0.03% | 663 |
|
2019
Q1 | $719M | Buy |
8,155,857
+76,039
| +0.9% | +$6.7M | 0.03% | 615 |
|
2018
Q4 | $577M | Buy |
8,079,818
+307,582
| +4% | +$22M | 0.03% | 643 |
|
2018
Q3 | $956M | Buy |
7,772,236
+204,065
| +3% | +$25.1M | 0.04% | 537 |
|
2018
Q2 | $743M | Buy |
7,568,171
+257,865
| +4% | +$25.3M | 0.03% | 598 |
|
2018
Q1 | $606M | Buy |
7,310,306
+184,913
| +3% | +$15.3M | 0.03% | 653 |
|
2017
Q4 | $553M | Buy |
7,125,393
+101,951
| +1% | +$7.91M | 0.02% | 707 |
|
2017
Q3 | $430M | Buy |
7,023,442
+101,148
| +1% | +$6.2M | 0.02% | 786 |
|
2017
Q2 | $318M | Buy |
6,922,294
+186,329
| +3% | +$8.57M | 0.02% | 946 |
|
2017
Q1 | $292M | Buy |
6,735,965
+293,755
| +5% | +$12.7M | 0.02% | 979 |
|
2016
Q4 | $249M | Buy |
6,442,210
+153,953
| +2% | +$5.96M | 0.01% | 1030 |
|
2016
Q3 | $318M | Buy |
6,288,257
+208,888
| +3% | +$10.6M | 0.02% | 824 |
|
2016
Q2 | $276M | Sell |
6,079,369
-7,353
| -0.1% | -$334K | 0.02% | 868 |
|
2016
Q1 | $241M | Buy |
6,086,722
+148,691
| +3% | +$5.88M | 0.02% | 922 |
|
2015
Q4 | $336M | Buy |
5,938,031
+175,693
| +3% | +$9.94M | 0.02% | 741 |
|
2015
Q3 | $229M | Buy |
5,762,338
+399,910
| +7% | +$15.9M | 0.02% | 914 |
|
2015
Q2 | $256M | Buy |
5,362,428
+1,419,573
| +36% | +$67.8M | 0.02% | 904 |
|
2015
Q1 | $157M | Buy |
3,942,855
+1,581,276
| +67% | +$62.8M | 0.01% | 1183 |
|
2014
Q4 | $52.8M | Buy |
2,361,579
+77,743
| +3% | +$1.74M | ﹤0.01% | 1806 |
|
2014
Q3 | $35.8M | Buy |
2,283,836
+68,679
| +3% | +$1.08M | ﹤0.01% | 1963 |
|
2014
Q2 | $32.9M | Sell |
2,215,157
-5,985
| -0.3% | -$88.8K | ﹤0.01% | 2033 |
|
2014
Q1 | $35.8M | Buy |
2,221,142
+334,323
| +18% | +$5.38M | ﹤0.01% | 1973 |
|
2013
Q4 | $17.6M | Buy |
1,886,819
+59,305
| +3% | +$554K | ﹤0.01% | 2213 |
|
2013
Q3 | $20.7M | Buy |
1,827,514
+19,130
| +1% | +$217K | ﹤0.01% | 2098 |
|
2013
Q2 | $24.2M | Buy |
+1,808,384
| New | +$24.2M | ﹤0.01% | 2003 |
|